New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
09:00 EDTHPTXHyperion Therapeutics falls 4.5%
Hyperion Therapeutics is down 4.5%, or $1.31, to $28.00
News For HPTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
08:43 EDTHPTXHyperion Therapeutics management to meet with Needham
Meetings to be held in Detroit/Chicago on March 31 and in Chicago on April 1 hosted by Needham.
March 25, 2015
11:01 EDTHPTXHyperion Therapeutics price target raised to $51 from $40 at Brean Capital
Subscribe for More Information
March 23, 2015
11:16 EDTHPTXHyperion Therapeutics price target raised to $52 from $36 at Wedbush
Wedbush raised Hyperion's price target to $52 ahead of the hepatic encephalopathy Phase III trial of Ravicti and the likelihood of success. Shares are Outperform rated.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use